期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Effectiveness and Controversy of Convalescent Plasma Therapy for Coronavirus Disease 2019 Patients 被引量:1
1
作者 Zhanjun Shu Peipei Wu +5 位作者 Qianqian Qian Li Zhou Dandan Du Mengxuan Ding Tao Peng Ke Fang 《Infectious Diseases & Immunity》 2022年第1期49-54,共6页
Since the coronavirus disease 2019(COVID-19)began to spread,it remains pandemic worldwide.The European Medicines Agency’s human medicines committee and Food and Drug Administration have only granted a conditional mar... Since the coronavirus disease 2019(COVID-19)began to spread,it remains pandemic worldwide.The European Medicines Agency’s human medicines committee and Food and Drug Administration have only granted a conditional marketing authorization for remdesivir to treat COVID-19.It is essential to apply other valuable treatments.Convalescent plasma(CP),donated by persons who have recovered from COVID-19,is the cellular component of blood that contains specific antibodies.Therefore,to determine the feasibility of CP for COVID-19,the effectiveness and controversy are discussed in depth here.It is suggested that CP plays a certain role in the treatment of COVID-19.As a treatment,it may have its own indications and contraindications,which need to be further discussed.Meanwhile,it is critical to establish a standard procedure for treatment from CP collection,preservation,transport,to transfusion,and conduct some large sample randomized controlled trials to confirm the transfusion dosage,appropriate time,frequency,and actively prevent adverse outcomes that may occur. 展开更多
关键词 COVID-19 Controversy Convalescent plasma EFFECTIVENESS THERAPY
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部